Document is current
Any future updates will be listed below
-
Authors
Ruisch, Anika
Ntopi, Simon
Mathur, Ishani
Conlin, Maeve
McCaffrey, Anna
Walker, Damian G.
Suharlim, Christian
-
Funding
Funding for this research was provided by:
United States Agency for International Development (7200AA18C00074, 7200AA18C00074, 7200AA18C00074, 7200AA18C00074, 7200AA18C00074, 7200AA18C00074, 7200AA18C00074)
- License Information
-
More Information
Article History
Received: 19 July 2024
Accepted: 24 February 2025
First Online: 22 July 2025
Declarations
:
: The costing study was conducted as part of the USAID’s Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program and carried out by Management Sciences for Health (MSH). This study was reviewed and approved on October 28, 2022, by Malawi’s Ministry of Health (MoH) local institutional review board, the National Health Sciences Research Committee (NHSRC; IRB number: IRB00003905; FWA: 00005976).
: The authors declare no competing interests.
